BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7502811)

  • 1. 4D5.4, a monoclonal antibody which recognizes cells in inflamed human intestine.
    Taylor J; MacDonald TT; Spencer J
    Adv Exp Med Biol; 1995; 371B():1331-2. PubMed ID: 7502811
    [No Abstract]   [Full Text] [Related]  

  • 2. Living on the edge: immune cells and immunopathology in the intestinal mucosa.
    Brunner T
    Semin Immunopathol; 2009 Jul; 31(2):143-4. PubMed ID: 19495756
    [No Abstract]   [Full Text] [Related]  

  • 3. [In situ expression of interleukin-10 messenger RNA in Crohn disease and ulcerative colitis].
    Autschbach F; Schürmann G; Braunstein J; Niemir Z; Wallich R; Otto HF; Meuer SC
    Verh Dtsch Ges Pathol; 1996; 80():218. PubMed ID: 9065011
    [No Abstract]   [Full Text] [Related]  

  • 4. Crypt hyperplasia related to increased lymphocyte activation in the rectal mucosa of children with ulcerative colitis.
    Arato A; Savilahti E; Paszti I
    Z Gastroenterol; 1994 Sep; 32(9):483-7. PubMed ID: 7801653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF alpha secreting cells in normal and diseased human intestine.
    Breese E; MacDonald TT
    Adv Exp Med Biol; 1995; 371B():821-4. PubMed ID: 7502905
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative immunohistochemical features of Crohn disease and ulcerative colitis].
    Ioffe AIu
    Lik Sprava; 2005; (5-6):33-5. PubMed ID: 16396288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell activation and proliferation in the large intestine of patients with Crohn's disease or ulcerative colitis and controls.
    Ullrich R; Schneider T; Schieferdecker HL; Jahn HU; Riecken EO; Zeitz M
    Adv Exp Med Biol; 1995; 371B():1281-2. PubMed ID: 7502800
    [No Abstract]   [Full Text] [Related]  

  • 8. [Features of inflammation of the mucosa of the large intestine in nonspecific ulcerative colitis and Crohn's disease].
    Novikova AV; Shcherbakov IT; Ol'shanskiĭ IaO; Iurkov MM; Levitan MKh
    Arkh Patol; 1982; 44(9):31-9. PubMed ID: 6756359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on lymphocyte subpopulations in the intestinal lamina propria in inflammatory bowel diseases.
    Yuan SZ; Foster LP; Wang NS; Kraft SC
    Chin Med J (Engl); 1992 Jan; 105(1):18-24. PubMed ID: 1576865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunologic basis of inflammatory bowel disease.
    Strober W; James SP
    J Clin Immunol; 1986 Nov; 6(6):415-32. PubMed ID: 2878011
    [No Abstract]   [Full Text] [Related]  

  • 11. Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease.
    Binion DG; West GA; Volk EE; Drazba JA; Ziats NP; Petras RE; Fiocchi C
    Lancet; 1998 Nov; 352(9142):1742-6. PubMed ID: 9848350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunofluorescence study of the intestinal mucosa in ulcerative colitis and Crohn's disease.
    Green FH; Fox H
    J Pathol; 1973 Jul; 110(3):Pii. PubMed ID: 4582851
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: A study by immunofluorescence of the intestinal mucosa in ulcerative colitis and Crohn's disease.
    Green FH; Fox H
    J Med Microbiol; 1973 Nov; 6(4):P18. PubMed ID: 4587399
    [No Abstract]   [Full Text] [Related]  

  • 14. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.
    Chinen H; Matsuoka K; Sato T; Kamada N; Okamoto S; Hisamatsu T; Kobayashi T; Hasegawa H; Sugita A; Kinjo F; Fujita J; Hibi T
    Gastroenterology; 2007 Aug; 133(2):559-73. PubMed ID: 17681176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and density of TNF immunoreactivity in chronic inflammatory bowel disease.
    Murch SH; Braegger CP; Walker-Smith JA; MacDonald TT
    Adv Exp Med Biol; 1995; 371B():1327-30. PubMed ID: 7502810
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
    Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
    Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-ANCA as a differential diagnostic marker in inflammatory bowel disease.
    Oberstadt K; Schaedel W; Weber M; Classen M; Deusch K
    Adv Exp Med Biol; 1995; 371B():1313-6. PubMed ID: 7502807
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunohistologic studies of differential HLA expression in patients with various intestinal diseases].
    Zschaler U; Weber P; Jedrychowski A; Wiedmann KH
    Z Gastroenterol; 1991 Mar; 29(3):92-100. PubMed ID: 2058237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alpha-2A (roferon) as a treatment of inflammatory bowel disease in children and adolescents.
    Hadziselimovic F; Schaub U; Emmons LR
    Adv Exp Med Biol; 1995; 371B():1323-6. PubMed ID: 7502809
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular hypersensitivity to intestinal mucosa components in ulcerative colitis and Chrohn's disease.
    Bendixen G
    Tijdschr Gastroenterol; 1970; 13(6):459-66. PubMed ID: 5519339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.